Clinical Trial Update: Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating deferoxamine to prevent delayed cerebral ischemia after subarachnoid hemorrhage was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Subarachnoid Hemorrhage | EARLY_Phase 1 | Status: TERMINATED